Docetaxel in Combination With Novel Therapies in Prostate Cancer: Promising Phase III Trials Ongoing
May 29th 2012
To date, no studies of novel therapies combined with docetaxel and prednisone have demonstrated improvement in their designated endpoints. However, several promising combination trials are ongoing.